Inconsistent Protective Efficacy and Marked Polymorphism Limits the Value of Schistosoma japonicum Tetraspanin-2 as a Vaccine Target

BACKGROUND: Schistosoma mansoni tetraspanin 2 (Sm-TSP-2) has been shown to be strongly recognized by IgG1 and IgG3 antibodies from individuals putatively resistant to schistosome infection, but not chronically infected people, and to induce high levels of protection against challenge infection in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenbao, Li, Jun, Duke, Mary, Jones, Malcolm K., Kuang, Ling, Zhang, Jianfeng, Blair, David, Li, Yuesheng, McManus, Donald P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104969/
https://www.ncbi.nlm.nih.gov/pubmed/21655308
http://dx.doi.org/10.1371/journal.pntd.0001166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104969/
https://www.ncbi.nlm.nih.gov/pubmed/21655308
http://dx.doi.org/10.1371/journal.pntd.0001166

Ejemplares similares